<?xml version='1.0' encoding='UTF-8'?>
<algorithm name="Grobid Header Extraction" version="0.1"><title>The Benefit and Burden of Cancer Screening in Li-Fraumeni Syndrome: A Case Report</title><authors><author><name>Ami P Jhaveri</name><affiliation>Yale School of Medicine, Smilow Cancer Hospital, Section of Medical Oncology</affiliation></author><author><name>Allen Bale</name><affiliation>Yale School of Medicine, Smilow Cancer Hospital, Cancer Genetics and Prevention Program | Yale School of Medicine, Department of Genetics</affiliation></author><author><name>Niki Lovick</name><affiliation>Yale School of Medicine, Smilow Cancer Hospital, Cancer Genetics and Prevention Program</affiliation></author><author><name>Kaye Zuckerman</name><affiliation>Yale School of Medicine, Department of Surgery</affiliation></author><author><name>Hari Deshpande</name><affiliation>Yale School of Medicine, Smilow Cancer Hospital, Section of Medical Oncology</affiliation></author><author><name>Kristina Rath</name><affiliation>Yale School of Medicine, Department of Obstetrics and Gynecology</affiliation></author><author><name>Peter Schwartz</name><affiliation>Yale School of Medicine, Department of Obstetrics and Gynecology</affiliation></author><author><name>Erin W Hofstatter</name><affiliation>Yale School of Medicine, Smilow Cancer Hospital, Section of Medical Oncology | Yale School of Medicine, Smilow Cancer Hospital, Cancer Genetics and Prevention Program</affiliation></author></authors><keywords /></algorithm><TEI>
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Benefit and Burden of Cancer Screening in Li-Fraumeni Syndrome: A Case Report</title>
			</titleStmt>
			<publicationStmt>
				<publisher />
				<availability status="unknown"><licence /></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Ami</forename>
								<forename type="middle">P</forename>
								<surname>Jhaveri</surname>
							</persName>
							<affiliation>
								<orgName type="department">Section of Medical Oncology</orgName>
								<orgName key="instit1" type="institution">Yale School of Medicine</orgName>
								<orgName key="instit2" type="institution">Smilow Cancer Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Allen</forename>
								<surname>Bale</surname>
							</persName>
							<affiliation>
								<orgName type="department">Cancer Genetics and Prevention Program</orgName>
								<orgName key="instit1" type="institution">Yale School of Medicine</orgName>
								<orgName key="instit2" type="institution">Smilow Cancer Hospital</orgName>
							</affiliation>
							<affiliation>
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">Yale School of Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Niki</forename>
								<surname>Lovick</surname>
							</persName>
							<affiliation>
								<orgName type="department">Cancer Genetics and Prevention Program</orgName>
								<orgName key="instit1" type="institution">Yale School of Medicine</orgName>
								<orgName key="instit2" type="institution">Smilow Cancer Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Kaye</forename>
								<surname>Zuckerman</surname>
							</persName>
							<affiliation>
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">Yale School of Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Hari</forename>
								<surname>Deshpande</surname>
							</persName>
							<affiliation>
								<orgName type="department">Section of Medical Oncology</orgName>
								<orgName key="instit1" type="institution">Yale School of Medicine</orgName>
								<orgName key="instit2" type="institution">Smilow Cancer Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Kristina</forename>
								<surname>Rath</surname>
							</persName>
							<affiliation>
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">Yale School of Medicine</orgName>
								<address>
									<settlement>New Haven, Connecticut</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Peter</forename>
								<surname>Schwartz</surname>
							</persName>
							<affiliation>
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">Yale School of Medicine</orgName>
								<address>
									<settlement>New Haven, Connecticut</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Erin</forename>
								<forename type="middle">W</forename>
								<surname>Hofstatter</surname>
							</persName>
							<affiliation>
								<orgName type="department">Section of Medical Oncology</orgName>
								<orgName key="instit1" type="institution">Yale School of Medicine</orgName>
								<orgName key="instit2" type="institution">Smilow Cancer Hospital</orgName>
							</affiliation>
							<affiliation>
								<orgName type="department">Cancer Genetics and Prevention Program</orgName>
								<orgName key="instit1" type="institution">Yale School of Medicine</orgName>
								<orgName key="instit2" type="institution">Smilow Cancer Hospital</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">The Benefit and Burden of Cancer Screening in Li-Fraumeni Syndrome: A Case Report</title>
					</analytic>
					<monogr>
						<imprint>
							<date />
						</imprint>
					</monogr>
					<note>181</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract />
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
	</text>
</TEI><algorithms version="110505">
<algorithm name="ParsCit" version="110505">
<citationList>
<citation valid="false">
<authors>
<author>181Copyright</author>
</authors>
<title>The Benefit and Burden of Cancer Screening in Li-Fraumeni Syndrome: A Case Report</title>
<date>2015</date>
<location>New Haven, Connecticut</location>
<marker>181Copyright, 2015</marker>
<rawString> 181Copyright Â© 2015 The Benefit and Burden of Cancer Screening in Li-Fraumeni Syndrome: A Case Report Ami P. Jhaveria, Allen Baleb,c, Niki Lovickb, Kaye Zuckermand, Hari Deshpandea, Kristina Rathe, Peter Schwartze, and Erin W. Hofstattera,b* aSection of Medical Oncology, Yale School of Medicine/Smilow Cancer Hospital; bCancer Genetics and Prevention Program, Yale School of Medicine/Smilow Cancer Hospital; cDepartment of Genetics, Yale School of Medicine; dDepartment of Surgery, Yale School of Medicine; eDepartment of Obstetrics and Gynecology, Yale School of Medicine, New Haven, Connecticut</rawString>
</citation>
<citation valid="false">
<authors>
<author>Li FP</author>
<author>Fraumeni JF Jr</author>
</authors>
<title>Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med.</title>
<pages>1969--71</pages>
<marker>1.</marker>
<rawString>Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969;71(4):747-52.</rawString>
</citation>
<citation valid="true">
<authors>
<author>Li FP</author>
<author>Fraumeni JF Jr</author>
<author>Mulvihill JJ</author>
<author>Blattner WA</author>
<author>Dreyfus MG</author>
<author>Tucker MA</author>
</authors>
<title>A cancer family syndrome in twentyfour kindreds. Cancer Res.</title>
<date>1988</date>
<marker>2.</marker>
<rawString>Li FP, Fraumeni JF Jr., Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twentyfour kindreds. Cancer Res. 1988;48(18):5358-62.</rawString>
</citation>
<citation valid="false">
<authors>
<author>Gonzalez KD</author>
<author>Noltner KA</author>
<author>Buzin CH</author>
<author>D Gu</author>
<author>Wen-Fong CY</author>
<author>Nguyen VQ</author>
</authors>
<title>Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations.</title>
<journal>J Clin Oncol.</journal>
<pages>2009--27</pages>
<marker>3.</marker>
<rawString>Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, et al. Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations. J Clin Oncol. 2009;27(8):1250-6.</rawString>
</citation>
<citation valid="false">
<authors>
<author>D Malkin</author>
</authors>
<title>Li-fraumeni syndrome.</title>
<journal>Genes Cancer.</journal>
<pages>2011--2</pages>
<marker>4.</marker>
<rawString>Malkin D. Li-fraumeni syndrome. Genes Cancer. 2011;2(4):475-84.</rawString>
</citation>
<citation valid="false">
<authors>
<author>A Chompret</author>
<author>L Brugieres</author>
<author>M Ronsin</author>
<author>M Gardes</author>
<author>F DessarpsFreichey</author>
<author>A Abel</author>
</authors>
<title>P53 germline mutations in childhood cancers and cancer risk for carrier individuals.</title>
<journal>Br J Cancer.</journal>
<pages>2000--82</pages>
<marker>5.</marker>
<rawString>Chompret A, Brugieres L, Ronsin M, Gardes M, DessarpsFreichey F, Abel A, et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer. 2000;82(12):1932-7.</rawString>
</citation>
<citation valid="true">
<authors>
<author>Wu CC</author>
<author>S Shete</author>
<author>Amos CI</author>
<author>Strong LC</author>
</authors>
<title>Joint effects of germline p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res.</title>
<date>2006</date>
<marker>6.</marker>
<rawString>Wu CC, Shete S, Amos CI, Strong LC. Joint effects of germline p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res. 2006;66:8287.</rawString>
</citation>
<citation valid="true">
<authors>
<author>M Hisada</author>
<author>Garber JE</author>
<author>Li FP</author>
<author>Fung CY</author>
<author>Fraumeni JF</author>
</authors>
<title>Multiple Primary Cancers in Families With Li-Fraumeni Syndrome.</title>
<date>1998</date>
<journal>J Natl Cancer Inst.</journal>
<marker>7.</marker>
<rawString>Hisada M, Garber JE, Li FP, Fung CY, Fraumeni JF. Multiple Primary Cancers in Families With Li-Fraumeni Syndrome. J Natl Cancer Inst. 1998;90(8):606-11.</rawString>
</citation>
<citation valid="false">
<authors>
<author>S Ognjanovic</author>
<author>M Olivier</author>
<author>Bergemann TL</author>
<author>P Hainaut</author>
</authors>
<title>Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.</title>
<journal>Cancer.</journal>
<pages>2012--118</pages>
<marker>8.</marker>
<rawString>Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer. 2012;118:1387-96.</rawString>
</citation>
<citation valid="false">
<authors>
<author>S Heymann</author>
<author>S Delaloge</author>
<author>A Rahal</author>
<author>O Caron</author>
<author>T Frebourg</author>
<author>L Barreau</author>
</authors>
<title>Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol.</title>
<pages>2010--5</pages>
<marker>9.</marker>
<rawString>Heymann S, Delaloge S, Rahal A, Caron O, Frebourg T, Barreau L, et al. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol. 2010;5:104.</rawString>
</citation>
<citation valid="false">
<authors>
<author>A Chompret</author>
<author>A Abel</author>
<author>D Stoppa-Lyonnet</author>
<author>L Brugieres</author>
<author>S Pages</author>
<author>J Feunteun</author>
</authors>
<title>Sensitivity and predictive value of criteria for p53 germline mutation screening.</title>
<journal>J Med Genet.</journal>
<pages>2001--38</pages>
<marker>10.</marker>
<rawString>Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J, et al. Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet. 2001;38(1):43-7.</rawString>
</citation>
<citation valid="true">
<authors>
<author>J Tinat</author>
<author>G Bougeard</author>
<author>S Baert-Desurmont</author>
<author>S Vasseur</author>
<author>C Martin</author>
<author>E Bouvignies</author>
</authors>
<title>version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol. 2009;27(26):e108-9; author reply e10.</title>
<date>2009</date>
<marker>11.</marker>
<rawString>Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, et al. 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol. 2009;27(26):e108-9; author reply e10.</rawString>
</citation>
<citation valid="false">
<authors>
<author>Lammens CR</author>
<author>Aaronson NK</author>
<author>A Wagner</author>
<author>Sijmons RH</author>
<author>Ausems MG</author>
<author>Vriends AH</author>
</authors>
<title>Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.</title>
<journal>J Clin Oncol.</journal>
<pages>2010--28</pages>
<marker>12.</marker>
<rawString>Lammens CR, Aaronson NK, Wagner A, Sijmons RH, Ausems MG, Vriends AH, et al. Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences. J Clin Oncol. 2010;28(18):3008-14.</rawString>
</citation>
<citation valid="false">
<authors>
<author>K Offit</author>
<author>K Kohut</author>
<author>B Clagett</author>
<author>Wadsworth EA</author>
<author>Lafaro KJ</author>
<author>S Cummings</author>
</authors>
<title>Cancer genetic testing and assisted reproduction.</title>
<journal>J Clin Oncol.</journal>
<pages>2006--24</pages>
<marker>13.</marker>
<rawString>Offit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S, et al. Cancer genetic testing and assisted reproduction. J Clin Oncol. 2006;24(29):4775-82.</rawString>
</citation>
<citation valid="false">
<authors>
<author>C Lammens</author>
<author>E Bleiker</author>
<author>N Aaronson</author>
<author>A Wagner</author>
<author>R Sijmons</author>
<author>M Ausems</author>
</authors>
<title>Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits. Fam Cancer.</title>
<pages>2010--9</pages>
<marker>14.</marker>
<rawString>Lammens C, Bleiker E, Aaronson N, Wagner A, Sijmons R, Ausems M, et al. Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits. Fam Cancer. 2010;9(4):647-54.</rawString>
</citation>
<citation valid="false">
<authors>
<author>A Villani</author>
<author>U Tabori</author>
<author>J Schiffman</author>
<author>A Shlien</author>
<author>J Beyene</author>
<author>H Druker</author>
</authors>
<title>Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 2011;12(6):559-67. 185Jhaveri et al.: Cancer screening in Li-Fraumeni syndrome</title>
<marker>15.</marker>
<rawString>Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 2011;12(6):559-67. 185Jhaveri et al.: Cancer screening in Li-Fraumeni syndrome</rawString>
</citation>
</citationList>
</algorithm>
</algorithms>